Filing metadata

Accession number
0001209191-21-058172
Form type
Form 3
Filer
Fusion Pharmaceuticals Inc.
CIK
CIK 1805890
Filed
Sep 30, 2021
Reporting period
Sep 27, 2021
Description
Initial ownership

Explore SEC Filings Hub